跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

D3676

Sigma-Aldrich

10-脱乙酰基巴卡汀III 来源于浆果紫杉

≥95% (HPLC)

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C29H36O10
CAS号:
32981-86-5
分子量:
544.59
MDL编号:
MFCD00132913
UNSPSC代码:
51102829
PubChem化学物质编号:
24893778
NACRES:
NA.85

生物来源

Taxus baccata

质量水平

200

方案

≥95% (HPLC)

表单

solid

分子量

544.59 g/mol

颜色

white

溶解性

methanol: soluble, clear, colorless (5 mg + 0.1 mL MeOH)

抗生素抗菌谱

neoplastics

作用机制

DNA synthesis | interferes

储存温度

2-8°C

SMILES字符串

[H][C@@]12C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C4=C(C)[C@@H](O)C[C@@](O)([C@@H](OC(=O)c5ccccc5)[C@]3([H])[C@@]1(CO2)OC(C)=O)C4(C)C

InChI

1S/C29H36O10/c1-14-17(31)12-29(36)24(38-25(35)16-9-7-6-8-10-16)22-27(5,23(34)21(33)20(14)26(29,3)4)18(32)11-19-28(22,13-37-19)39-15(2)30/h6-10,17-19,21-22,24,31-33,36H,11-13H2,1-5H3/t17-,18-,19+,21+,22-,24-,27+,28-,29+/m0/s1

InChI key

YWLXLRUDGLRYDR-ZHPRIASZSA-N

正在寻找类似产品? 访问 产品对比指南

应用

10-脱乙酰基浆果赤霉素III被用作制备抗癌药物紫杉醇（紫杉醇）的一种化学中间体。它被用于研究紫杉醇生物合成途径。

生化/生理作用

10-脱乙酰基浆果赤霉素III是紫杉醇生物合成的第五中间体。该生物合成通路由大约20个尚未被完全阐明的酶促步骤组成。

象形图

Health hazardExclamation mark
GHS08,GHS07

警示用语：

Danger

危险分类

Carc. 1B - Eye Irrit. 2 - Muta. 1B - Skin Irrit. 2 - STOT RE 2 - STOT SE 3

靶器官

Respiratory system

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

监管及禁止进口产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000360449
0000360449
SLBD3989V
SLBC7550V
054K1372

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ning Zhang et al.
Journal of proteome research, 17(7), 2256-2281 (2018-05-16)
Crops are often subjected to a combination of stresses in the field. To date, studies on the physiological and molecular responses of common wheat to a combination of osmotic and cold stresses, however, remain unknown. In this study, wheat seedlings
H Gelderblom et al.
Drug metabolism and disposition: the biological fate of chemicals, 27(11), 1300-1305 (1999-10-26)
In the present work, we studied the pharmacokinetics and metabolic disposition of [G-(3)H]paclitaxel in a female patient with recurrent ovarian cancer and severe renal impairment (creatinine clearance: approximately 20 ml/min) due to chronic hypertension and prior cisplatin treatment. During six
Simona Mozzetti et al.
Cancer research, 68(24), 10197-10204 (2008-12-17)
Patupilone is an epothilone in advanced clinical development that has shown promising efficacy in heavily pretreated patients. This study aimed at characterizing the mechanisms of patupilone activity in resistant patients. To this end, we generated patupilone-resistant cells using two cellular
Gorawit Yusakul et al.
Journal of biotechnology, 288, 41-47 (2018-11-06)
Formation of disulfide bonds between heavy and light chains is challenge for production of recombinant immunoglobulin G (IgG) and fragment antigen-binding (Fab). Insufficient formation of the bond influences productive yield and quality of recombinant IgG and Fab. To investigate how
Denis, J-N., et al.
Journal of the American Chemical Society, 110, 5917-5917 (1988)

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门